PubRank

S Fredrikson

Author PubWeight™ 96.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler 1999 4.91
2 Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry 1994 1.98
3 Neutralizing and binding anti-interferon-beta (IFN-beta) antibodies. A comparison between IFN-beta-1a and IFN-beta-1b treatment in multiple sclerosis. Eur J Neurol 2000 1.61
4 Costs and quality of life of patients with multiple sclerosis in Europe. J Neurol Neurosurg Psychiatry 2006 1.61
5 Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs. Mult Scler 2012 1.59
6 Increased incidence of Guillain-Barré syndrome postpartum. Epidemiology 1998 1.53
7 Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler 2011 1.51
8 Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens 2004 1.47
9 Guillain-Barré syndrome in south-west Stockholm, 1973-1991, 1. Quality of registered hospital diagnoses and incidence. Acta Neurol Scand 1995 1.46
10 Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci U S A 1989 1.36
11 Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur J Immunol 1991 1.36
12 Costs, quality of life and disease severity in multiple sclerosis: a cross-sectional study in Sweden. Eur J Neurol 2001 1.34
13 The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis. Genes Immun 2001 1.11
14 CSF neopterin as marker of disease activity in multiple sclerosis. Acta Neurol Scand 1987 1.10
15 Activities of daily living and social activities in people with multiple sclerosis in Stockholm County. Clin Rehabil 2006 1.03
16 Use of health care services and satisfaction with care in people with multiple sclerosis in Stockholm County: a population-based study. Mult Scler 2008 1.02
17 Parkinson's disease and immunological abnormalities: increase of HLA-DR expression on monocytes in cerebrospinal fluid and of CD45RO+ T cells in peripheral blood. Acta Neurol Scand 1994 1.01
18 Health-related quality of life in a population-based sample of people with multiple sclerosis in Stockholm County. Mult Scler 2006 0.99
19 IL-15 mRNA expression is up-regulated in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis (MS). Clin Exp Immunol 1998 0.97
20 Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study. Eur Neurol 2007 0.97
21 Multiple sclerosis is associated with high levels of circulating dendritic cells secreting pro-inflammatory cytokines. J Neuroimmunol 1999 0.96
22 Multiple sclerosis: levels of interleukin-10-secreting blood mononuclear cells are low in untreated patients but augmented during interferon-beta-1b treatment. Scand J Immunol 1999 0.96
23 Cost-utility of interferon beta1b in the treatment of patients with active relapsing-remitting or secondary progressive multiple sclerosis. Eur J Health Econ 2003 0.94
24 A population-based study of depressive symptoms in multiple sclerosis in Stockholm county: association with functioning and sense of coherence. J Neurol Neurosurg Psychiatry 2006 0.94
25 Virus-reactive and autoreactive T cells are accumulated in cerebrospinal fluid in multiple sclerosis. J Neuroimmunol 1992 0.94
26 Absence of seven human herpesviruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis. Acta Neurol Scand 1997 0.93
27 Organ-specific autoantigens induce interferon-gamma and interleukin-4 mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis. Neurology 1994 0.92
28 Linkage and association analysis of susceptibility regions on chromosomes 5 and 6 in 106 Scandinavian sibling pair families with multiple sclerosis. Ann Neurol 1999 0.91
29 Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis. Mult Scler 2009 0.91
30 Multiple sclerosis: the proinflammatory cytokines lymphotoxin-alpha and tumour necrosis factor-alpha are upregulated in cerebrospinal fluid mononuclear cells. J Neuroimmunol 1996 0.90
31 HLA class II genes in chronic progressive and in relapsing/remitting multiple sclerosis. Lancet 1987 0.90
32 Cognitive and motor function in people with multiple sclerosis in Stockholm County. Mult Scler 2006 0.89
33 Cost-utility analysis of interferon beta-1b in secondary progressive multiple sclerosis. Int J Technol Assess Health Care 2000 0.89
34 Augmented expression of tumour necrosis factor-alpha and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis. Brain 1996 0.89
35 The HLA-Dw2 haplotype segregates closely with multiple sclerosis in multiplex families. J Neuroimmunol 1994 0.88
36 A genome-wide screen for linkage in Nordic sib-pairs with multiple sclerosis. Genes Immun 2002 0.88
37 Increased mRNA expression of IL-10 in mononuclear cells in multiple sclerosis and optic neuritis. Scand J Immunol 1995 0.87
38 Organ-specific autoantigens induce transforming growth factor-beta mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis. Ann Neurol 1994 0.87
39 Interleukin-2 secreting cells in multiple sclerosis and controls. J Neurol Sci 1993 0.87
40 Chronic fatigue syndrome differs from fibromyalgia. No evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome. Pain 1998 0.87
41 Lyme neuroborreliosis: evidence for persistent up-regulation of Borrelia burgdorferi-reactive cells secreting interferon-gamma. Scand J Immunol 1995 0.87
42 Multiple sclerosis: pro- and anti-inflammatory cytokines and metalloproteinases are affected differentially by treatment with IFN-beta. J Neuroimmunol 2000 0.86
43 Interleukin-6 is elevated in plasma in multiple sclerosis. J Neuroimmunol 1991 0.86
44 gamma delta+ T cells are increased in patients with Parkinson's disease. J Neurol Sci 1994 0.86
45 T cells recognizing multiple peptides of myelin basic protein are found in blood and enriched in cerebrospinal fluid in optic neuritis and multiple sclerosis. Scand J Immunol 1993 0.86
46 Cells producing antibodies specific for myelin basic protein region 70-89 are predominant in cerebrospinal fluid from patients with multiple sclerosis. Eur J Immunol 1991 0.85
47 Tumor necrosis factor-alpha, lymphotoxin, interleukin (IL)-6, IL-10, IL-12 and perforin mRNA expression in mononuclear cells in response to acetylcholine receptor is augmented in myasthenia gravis. J Neuroimmunol 1996 0.85
48 Analysis of CD27 surface expression on T cell subsets in MS patients and control individuals. J Neuroimmunol 1995 0.84
49 T cell responses to human recombinant acetylcholine receptor-alpha subunit in myasthenia gravis and controls. Eur J Immunol 1992 0.84
50 Multiple sclerosis in Stockholm County. A pilot study of utilization of health-care resources, patient satisfaction with care and impact on family caregivers. Acta Neurol Scand 2002 0.84
51 Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. Acta Neurol Scand 2011 0.83
52 The phosphodiesterase i.v. inhibitor rolipram in vitro reduces the numbers of MBP-reactive IFN-gamma and TNF-alpha mRNA expressing blood mononuclear cells in patients with multiple sclerosis. Clin Neuropharmacol 1998 0.83
53 Interferon-beta treatment for patients with multiple sclerosis: the patients' perceptions of the side-effects. Mult Scler 2000 0.83
54 [Place of residence determines access to interferon-beta therapy in MS. Less than 15 per cent of patients are treated--big differences between the counties]. Lakartidningen 1999 0.83
55 Clinical features of patients with multiple sclerosis from a survey in Shanghai, China. Mult Scler 2008 0.83
56 Total, anti-viral, and anti-myelin IgG subclass reactivity in inflammatory diseases of the central nervous system. J Neurol 1989 0.83
57 Incidence of Guillain-Barré syndrome in Sweden 1996. Eur J Neurol 2000 0.83
58 Bilateral subdural haematomas following lumbar puncture in three haematopoietic stem cell transplant recipients. Bone Marrow Transplant 1999 0.82
59 Humoral response to hsp 65 and hsp 70 in cerebrospinal fluid in Parkinson's disease. J Neurol Sci 1996 0.82
60 Use of Complementary and Alternative Medicine among People with Multiple Sclerosis in the Nordic Countries. Autoimmune Dis 2012 0.82
61 Altered phenotype and function of blood dendritic cells in multiple sclerosis are modulated by IFN-beta and IL-10. Clin Exp Immunol 2001 0.82
62 Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis. J Neuroimmunol 1996 0.81
63 Optic neuritis and multiple sclerosis: the T cell repertoires to myelin proteins and MBP peptides change with time. Acta Neurol Scand 1994 0.81
64 Epidemiological surveillance of Guillain-Barré syndrome in Sweden, 1996-1997. Network members of the Swedish GBS Epidemiology Study Group. Acta Neurol Scand 2000 0.81
65 Decreased mRNA expression of TNF-alpha and IL-10 in non-stimulated peripheral blood mononuclear cells in myasthenia gravis. Eur J Neurol 2000 0.81
66 Autoimmune T cell repertoire in optic neuritis and multiple sclerosis: T cells recognising multiple myelin proteins are accumulated in cerebrospinal fluid. J Neurol Neurosurg Psychiatry 1994 0.81
67 Linkage and association analysis of genes encoding cytokines and myelin proteins in multiple sclerosis. J Neuroimmunol 1998 0.81
68 Multiple sclerosis in Stockholm County. A pilot study exploring the feasibility of assessment of impairment, disability and handicap by home visits. Clin Rehabil 2003 0.80
69 Similar humoral and cellular immunological reactivities to human herpesvirus 6 in patients with multiple sclerosis and controls. Clin Diagn Lab Immunol 1999 0.80
70 Transforming growth factor-beta 1 suppresses autoantigen-induced expression of pro-inflammatory cytokines but not of interleukin-10 in multiple sclerosis and myasthenia gravis. J Neuroimmunol 1995 0.80
71 Association and linkage analysis of candidate chromosomal regions in multiple sclerosis: indication of disease genes in 12q23 and 7ptr-15. Eur J Hum Genet 1999 0.80
72 Increased reactivity to HTLV-I in inflammatory nervous system diseases. Ann Neurol 1987 0.80
73 Intrathecal production of neopterin in aseptic meningo-encephalitis and multiple sclerosis. Clin Exp Immunol 1987 0.80
74 Guillain-Barré syndrome in South-West Stockholm, 1973-1991, 3. Clinicoepidemiological subgroups. Acta Neurol Scand 1996 0.80
75 Neutralising and binding anti-interferon-beta-I b (IFN-beta-I b) antibodies during IFN-beta-I b treatment of multiple sclerosis. Mult Scler 1997 0.79
76 Genomic HLA-typing by RFLP-analysis using DR beta and DQ beta cDNA probes reveals normal DR-DQ linkages in patients with multiple sclerosis. Tissue Antigens 1987 0.79
77 Interleukin-12 and perforin mRNA expression is augmented in blood mononuclear cells in multiple sclerosis. Scand J Immunol 1998 0.79
78 Augmented interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in blood mononuclear cells in myasthenia gravis. J Neuroimmunol 1994 0.79
79 Cytokine mRNA profiles in mononuclear cells in acute aseptic meningoencephalitis. Infect Immun 1995 0.79
80 Combination ELISAs for antiviral antibodies in CSF and serum in patients with neurological symptoms and in healthy controls. J Virol Methods 1988 0.79
81 The T-cell repertoire in myasthenia gravis involves multiple cholinergic receptor epitopes. Scand J Immunol 1992 0.78
82 Rate of ventricular enlargement in multiple sclerosis: a nine-year magnetic resonance imaging follow-up study. Acta Radiol 2008 0.78
83 A new cell enzyme-linked immunosorbent assay demonstrates gamma interferon suppression by beta interferon in multiple sclerosis. Clin Diagn Lab Immunol 1999 0.78
84 Callosal atrophy in multiple sclerosis is related to cognitive speed. Acta Neurol Scand 2012 0.78
85 Familial clustering of multiple sclerosis in a northern Swedish rural district. J Neurol Neurosurg Psychiatry 1994 0.78
86 Incidental MRI lesions suggestive of multiple sclerosis in asymptomatic patients in Karachi, Pakistan. J Neurol Neurosurg Psychiatry 2010 0.77
87 Linkage analysis of HLA class II genes in Swedish multiplex families with multiple sclerosis. Neurology 1997 0.77
88 The HLA-D region-associated MS-susceptibility genes may be located telomeric to the HLA-DP subregion. Tissue Antigens 1990 0.77
89 High numbers of autoantigen-reactive mononuclear cells expressing interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) are present in cord blood. Clin Exp Immunol 1995 0.77
90 CD5+ B cells and CD4-8-T cells in neuroimmunological diseases. J Neuroimmunol 1991 0.77
91 A population-based survey of multiple sclerosis in Shanghai, China. Neurology 2007 0.76
92 V region T cell receptor repertoire in Parkinson's disease. Acta Neurol Scand 1996 0.76
93 The B-cell repertoire in myasthenia gravis includes all four acetylcholine receptor subunits. Acta Neurol Scand 1998 0.76
94 The myelin basic protein gene in multiple sclerosis: identification of discrete alleles of a 1.3 kb tetranucleotide repeat sequence. Acta Neurol Scand 1998 0.76
95 Myasthenia gravis: T and B cell reactivities to the beta-bungarotoxin binding protein presynaptic membrane receptor. J Neurol Sci 1992 0.76
96 No evidence for elevated numbers of mononuclear cells expressing MCP-1 and RANTES mRNA in blood and CSF in multiple sclerosis. J Neuroimmunol 1998 0.76
97 Soluble CD30 levels in plasma and cerebrospinal fluid in multiple sclerosis, HIV infection and other nervous system diseases. Acta Neurol Scand 1997 0.76
98 Expression of IFN-gamma, IL-4, and TGF-beta in multiple sclerosis in relation to HLA-Dw2 phenotype and stage of disease. Mult Scler 1995 0.75
99 Evaluation of multiple sclerosis diagnostic criteria in Suzhou, China--risk of under-diagnosis in a low prevalence area. Acta Neurol Scand 2009 0.75
100 Primary lateral sclerosis. Arch Neurol 1989 0.75
101 High numbers of perforin mRNA expressing CSF cells in multiple sclerosis patients with gadolinium-enhancing brain MRI lesions. Acta Neurol Scand 1999 0.75
102 HLA-DR expression and neopterin levels as activity markers in multiple sclerosis. Riv Neurol 1987 0.75
103 Bone marrow cells in multiple sclerosis. A functional and phenotypic study. Ann N Y Acad Sci 1988 0.75
104 [Cognitive and affective dysfunction in MS]. Nord Med 1998 0.75
105 Multiple sclerosis in Pakistan. Mult Scler 2007 0.75
106 Linomide (roquinimex) affects the balance between pro- and anti-inflammatory cytokines in vitro in multiple sclerosis. Acta Neurol Scand 1998 0.75
107 Guillain-Barré syndrome in south-west Stockholm, 1973-1991, 2. Clinical epidemiology. Ital J Neurol Sci 1997 0.75
108 [Acute hemorrhagic leukoencephalitis is often misdiagnosed as herpes encephalitis]. Lakartidningen 1989 0.75
109 Multiple sclerosis and amyloid deposits in the white matter of the brain. Acta Neuropathol 1997 0.75
110 [Multiple sclerosis--the great imitator!]. Nord Med 1995 0.75
111 Clinical epidemiology of Guillain-Barré syndrome in adults in Sweden 1996-97: a prospective study. Eur J Neurol 2000 0.75
112 First hospital-admission rate as an epidemiological indicator for patients with multiple sclerosis in Stockholm, 1984-1993. Acta Neurol Scand 1999 0.75
113 A case-control study of Guillain-Barré syndrome in Harbin, China. Eur J Neurol 2006 0.75
114 Reports of patients and relatives from the CogniCIS study about cognition in clinically isolated syndrome: what are our patients telling us? Eur Neurol 2013 0.75
115 One-dimensional-ratio measures of atrophy progression in multiple sclerosis as evaluated by longitudinal magnetic resonance imaging. Acta Radiol 2009 0.75
116 [Disease activity in multiple sclerosis--is it possible to measure?]. Lakartidningen 1989 0.75
117 A zone immunoelectrophoresis assay method for quantification of apolipoprotein D in human cerebrospinal fluid. J Biochem Biophys Methods 1996 0.75
118 V delta 1 gene usage, interleukin-2 receptors and adhesion molecules on gamma delta+ T cells in inflammatory diseases of the nervous system. J Neuroimmunol 1994 0.75
119 Linkage analysis suggests a region of importance for multiple sclerosis in 3p14-13. Genes Immun 2001 0.75
120 [When and how should the diagnosis of multiple sclerosis be told to the patient--ethical dilemmas]. Lakartidningen 1989 0.75
121 [Wanted: families with multiple sclerosis]. Lakartidningen 1994 0.75
122 Retrovirus in multiple sclerosis. Acta Neurol Scand 1989 0.75
123 No evidence for increased frequency of autoantibodies during interferon-beta1b treatment of multiple sclerosis. Acta Neurol Scand 1998 0.75
124 Linkage analysis of a candidate region in Scandinavian sib pairs with multiple sclerosis reveals linkage to chromosome 17q. Genes Immun 2000 0.75